Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories

Dept. of Growth and Reproduction, University Hospital of Copenhagen, Denmark.

To compare interpretations of growth hormone (GH) provocative tests in laboratories using six different GH immunoassays (one enzymeimmunometric assay (EIMA, assay 1), one immunoradiometric assay (IRMA, assay 5), one time-resolved fluorimmunometric assay (TRFIA, assay 3) and three radioimmunoassays (RIAs, assays 2, 4 and 6)), aliquots of peak samples from GH provocative tests were distributed between the four participating laboratories, quantified in the respective immunoassays and interpreted according to the cut-off values for provocative tests defined for each assay method. There was a high degree of relative correlation between the different assays, but absolute GH estimates differed. Assays 2, 4, 5 and 6 yielded almost identical GH levels. Assays 1 and 3 yielded serum GH levels approximately 39% and 70%, respectively, of those of assays 2, 4, 5 and 6. Although the absolute GH level measured in the various assay methods varied, there was good agreement between the interpretation of a given sample among the participating laboratories. This indicates that the differences in estimates of serum GH concentration by different immunoassay systems can be compensated for when cut-off values are defined for each method.

This article has been cited by other articles:

				M. B. Hoos, K. R. Westerterp, and W.-J. M. Gerver Short-Term Effects of Growth Hormone on Body Composition as a Predictor of Growth J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2569 - 2572. [Abstract] [Full Text] [PDF]

				B. M. K. Biller, M. H. Samuels, A. Zagar, D. M. Cook, B. M. Arafah, V. Bonert, S. Stavrou, D. L. Kleinberg, J. J. Chipman, and M. L. Hartman Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2067 - 2079. [Abstract] [Full Text] [PDF]

				E. Chaler, A. Belgorosky, M. Maceiras, M. Mendioroz, and M. A. Rivarola Between-Assay Differences in Serum Growth Hormone (GH) Measurements: Importance in the Diagnosis of GH Deficiency in Childhood Clin. Chem., September 1, 2001; 47(9): 1735 - 1738. [Full Text] [PDF]

				M. B. Ranke, A. Lindberg, P. Chatelain, P. Wilton, W. Cutfield, K. Albertsson-Wikland, and D. A. Price Derivation and Validation of a Mathematical Model for Predicting the Response to Exogenous Recombinant Human Growth Hormone (GH) in Prepubertal Children with Idiopathic GH Deficiency J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1174 - 1183. [Abstract] [Full Text]

				S. M. Shalet, A. Toogood, A. Rahim, and B. M. D. Brennan The Diagnosis of Growth Hormone Deficiency in Children and Adults Endocr. Rev., April 1, 1998; 19(2): 203 - 223. [Abstract] [Full Text]

				C. Jansson, C. Boguszewski, S. Rosberg, L. Carlsson, and K. Albertsson-Wikland Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein Clin. Chem., June 1, 1997; 43(6): 950 - 956. [Abstract] [Full Text] [PDF]

				A. Juul, K. W. Kastrup, S. A. Pedersen, and N. E. Skakkebak Growth Hormone (GH) Provocative Retesting of 108 Young Adults with Childhood-Onset GH Deficiency and the Diagnostic Value of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-3 J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1195 - 1201. [Abstract] [Full Text] [PDF]